Collegium Pharmaceutical Inc (COLL)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 631,449 | 566,767 | 463,933 | 276,868 | 310,016 |
| Total assets | US$ in thousands | 1,663,590 | 1,143,310 | 1,174,130 | 692,077 | 643,841 |
| Total asset turnover | 0.38 | 0.50 | 0.40 | 0.40 | 0.48 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $631,449K ÷ $1,663,590K
= 0.38
The total asset turnover ratio for Collegium Pharmaceutical Inc has shown fluctuations over the past five years. In December 31, 2020, the total asset turnover was 0.48, indicating that the company generated $0.48 in revenue for every dollar invested in assets.
Subsequently, the ratio decreased to 0.40 by December 31, 2021, and remained at the same level by the end of 2022. This suggests a potential inefficiency in asset utilization during these periods.
However, in December 31, 2023, there was an improvement as the total asset turnover increased to 0.50, indicating the company generated more revenue per dollar of assets invested.
Unfortunately, by December 31, 2024, the total asset turnover dropped to 0.38, signaling a decline in efficiency in utilizing assets to generate revenue. Overall, Collegium Pharmaceutical Inc may need to focus on optimizing its asset management strategies to enhance its overall financial performance.
Peer comparison
Dec 31, 2024